[Expert consensus on the collaboration of medical and preventive care for the prevention and treatment of respiratory syncytial virus infection].

Respiratory syncytial virus (RSV) is the most common viral pathogen causing lower respiratory tract infections in humans, posing a hefty disease burden among infants, young children, and the elderly population, and representing a significant global public health concern. There is an urgent need in China to establish an integrated medical-preventive collaborative system for RSV infection control, encompassing"prevention, diagnosis, treatment and management, " to shift the focus from a "treatment-centered" to a "health-centered" strategy. To better guide and standardize RSV prevention and control measures in China, a multidisciplinary group of Chinese experts was formed to develop the " expert consensus on the collaboration of medical and preventive care for the prevention and treatment of respiratory syncytial virus infection". This consensus integrates existing evidence-based medical data and practical experiences from both domestic and international sources. Based on the strategic needs of RSV infection prevention and control in China, this consensus aims to provides innovative medical and preventive collaboration mechanisms and decision-making recommendations for medical institutions at all levels, disease prevention and control institutions, and relevant primary care professionals, with the aim of comprehensively enhancing the prevention and treatment level of RSV infection in China.